PERTURBED CELL-GROWTH AND ARA-C PHARMACOLOGY IN ACUTE MYELOID-LEUKEMIA (AML) AT DIAGNOSIS AND AT RELAPSE

被引：0
|
作者：
KARP, JE [1 ]
DONEHOWER, RC [1 ]
DOLE, GB [1 ]
BURKE, PJ [1 ]
机构：
[1] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
来源：
CELL AND TISSUE KINETICS | 1987年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [31] COMBINED ANTILEUKEMIC ACTIVITY OF PIXY-321 AND ARA-C AGAINST HUMAN ACUTE MYELOID-LEUKEMIA CELLS
    TANG, C
    HUANG, Y
    PONNATHPUR, VS
    RAY, S
    MAHONEY, ME
    BULLOCK, G
    IBRADO, AM
    BHALLA, K
    LEUKEMIA & LYMPHOMA, 1994, 15 (5-6) : 445 - 451
  • [32] Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML)
    Erba, H. P.
    Rizzieri, D. A.
    O'Donnell, M. R.
    Lundberg, A. S.
    Ajami, A. M.
    Rampersad, A. D.
    Capizzi, R. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] GROWTH-FACTOR REGULATION OF ACUTE MYELOID-LEUKEMIA (AML)
    LOWENBERG, B
    SANTINI, V
    DELWEL, HR
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 458 - 458
  • [34] INFLUENCE OF A NEW RELAPSE TREATMENT FOR ACUTE MYELOID-LEUKEMIA (AML) ON INVITRO GRANULOPOIESIS
    MULLER, MR
    SAUTER, C
    ERNI, J
    MARTZ, G
    ANTICANCER RESEARCH, 1983, 3 (02) : 127 - 131
  • [35] CORRELATION OF CYTOSINE-ARABINOSIDE (ARA-C) PHARMACOKINETICS, ARA-C PHOSPHORYLATION, INTRACELLULAR ARA-CTP HALF-LIFE AND EFFECTS ON DNA-SYNTHESIS IN ACUTE MYELOID-LEUKEMIA
    HARRIS, AL
    GRAHAMESMITH, DG
    BRITISH JOURNAL OF CANCER, 1981, 44 (02) : 284 - 284
  • [36] ROLE OF TRANSFERRIN AND TRANSFERRIN RECEPTORS IN MYELOID-LEUKEMIA CELL-GROWTH
    PFLUGER, KH
    GRUBER, A
    KOPPLER, H
    HAVEMANN, K
    BLUT, 1988, 57 (04): : 233 - 233
  • [37] RAPID REMISSION INDUCTION AND IMPROVED DISEASE FREE SURVIVAL IN ACUTE MYELOID-LEUKEMIA USING DAUNORUBICIN, ARA-C, AND CCNU
    BARRETT, AJ
    TRELEAVEN, JG
    SAMSON, DM
    EVANS, M
    GAMINARA, E
    FOADI, M
    MCCARTHY, DM
    LEUKEMIA & LYMPHOMA, 1990, 3 (02) : 139 - 144
  • [38] Pilot trial of Mylotarg, Topotecan and Ara-C in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Alvarez, RH
    Estey, EH
    Kantarjian, HM
    Giles, FJ
    Beran, M
    Thomas, D
    Cortes, JE
    BLOOD, 2002, 100 (11) : 340A - 341A
  • [39] Interim analysis of cytarabine (ara-C) and cladribine (2-CDA) combination therapy in acute myeloid leukemia (AML).
    Radomski, KM
    Gandhi, V
    Srivastava, DK
    Razzouk, BI
    Behm, FG
    Plunkett, W
    Pui, CH
    Rubnitz, JE
    Ribeiro, RC
    BLOOD, 2000, 96 (11) : 327A - 327A
  • [40] MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA
    SPADEA, A
    PETTI, MC
    FAZI, P
    VEGNA, ML
    ARCESE, W
    AVVISATI, G
    SPIRITI, MAA
    LATAGLIATA, R
    MELONI, G
    TESTI, AM
    AMADORI, S
    MANDELLI, F
    LEUKEMIA, 1993, 7 (04) : 549 - 552
12345